当前位置: X-MOL 学术Aliment. Pharm. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Corrigendum
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2021-10-26 , DOI: 10.1111/apt.16661
Stanislas Pol 1, 2 , Clovis Luzivika Nzinga 3 , Céline Dorival 3 , Fabien Zoulim 4 , Carole Cagnot 5 , Thomas Decaens 6 , Dominique Thabut 7 , Tarik Asselah 8 , Philippe Mathurin 9 , Nathalie Ganne 10, 11 , Didier Samuel 12, 13, 14 , François Habersetzer 15 , Jean-Pierre Bronowicki 16 , Dominique Guyader 17 , Isabelle Rosa 18 , Vincent Leroy 19 , Olivier Chazouilleres 20 , Victor De Ledinghen 21 , Marc Bourliere 22 , Xavier Causse 23 , Paul Cales 24, 25 , Sophie Metivier 26, 27 , Véronique Loustaud-Ratti 26 , Armand Abergel 28 , Hélène Fontaine 1 , Fabrice Carrat 3, 29 ,
Affiliation  

In the article entitled, ‘Similar 5-year HCC occurrence in Tenofovir- and Entecavir-treated HBV chronic infection in the French AFEF/ANRS CO22 Hepather cohort’,1 the complete list of authors and affiliations which should be provided in the article is,



中文翻译:

更正

在一篇题为“类似的5年肝癌发生在Tenofovir-和恩替卡韦治疗慢性HBV感染在法国AFEF / ANRS CO22 Hepather队列”,1应该在文章中提供的作者和所属单位的完整列表,

更新日期:2021-10-27
down
wechat
bug